Roche
Roche Receives EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test
The Cobas test is the first molecular, point-of-care test to receive Emergency Use Authorization for asymptomatic people.
A new publication detailing ctDNA testing results has spurred a minimal residual disease biomarker-directed trial for Roche's atezolizumab in bladder cancer.
Roche Gets CE Mark for SARS-CoV-2 Antigen Self Test
An earlier version of the test has been available in some European markets under local special approval pathways since February.
Illumina, Roche Agree to Settle NIPT Patent Lawsuits
The settlement will end a patent battle that has raged since 2012, but the terms have not yet been disclosed.
In Brief This Week: Roche Diagnostics, Amazon, Illumina, Sera Prognostics, and More
News items for the in vitro diagnostics industry for the week of May 17, 2021.
Mar 16, 2020
Mar 13, 2020
CMS Sets Payment Rate for SARS-CoV-2 Testing
Mar 11, 2020
Roche Cervical Pre-Cancer Test Garners FDA Approval
Feb 13, 2020
Jan 30, 2020
Dec 16, 2019
Roche Applies CE Mark to Zika Screening Test
Dec 14, 2019
Dec 10, 2019
Roche Blood Glucose Monitor App Receives CE Mark
Dec 5, 2019